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Visceral  Leishmaniasis  (kala-azar)  is  caused  by 
the intracellular parasitic organism Leishmania don-
ovani and is transmitted by the bite of an infected 
sandfly Phlebotomus argentipes. Clinical manifesta-
tions of advanced disease usually include constitu-
tional symptoms, such as prolonged fever, anorexia, 
weight loss, and marked enlargement of the spleen 
and liver, with varying degrees of pancytopenia [1].
Pakistan  is  a  tropical  country  situated  in  the 
north-west region of South Asia; all of its neighbor-
ing countries are endemic for Leishmaniasis, includ-
ing  China,  Afghanistan,  Iran,  and  India  [2-4].
Leishmaniasis was first reported from Pakistan in 
1960  [5].  Initially,  it  was  limited  to  the  northern 
mountainous region, but currently it is widespread 
throughout the country with several endemic foci of 
varying climatic and geographic conditions [6]. 
Herein  we  present  a  22-year-old  female  from 
Hyderabad,  Sindh  Province,  Pakistan  that  was 
referred to our laboratory for bone marrow exani-
mation due to pyrexia of unknown origin. She had 
fever with chills and rigors that began 2 months ear-
lier, which did not respond to treatment with anti-
malarials and multiple antibiotics. At presentation 
she had massive splenomegaly and marked pallor. 
Complete blood count showed the following: pan-
cytopenia  with  hypochromic  microcytic  anemia; 
hemoglobin: 7.1 g/dL; hematocrit: 21.8%; MCV: 72.5 
fL;  MCH:  23.8  pg;  MCHC:  29.7%;  total  white  cell 
count:  1.5×109/L;  absolute  neutrophil  count: 
0.4×109/L;  platelet  count:  48×109/L.  Peripheral 
blood  smear  did  not  show  a  leukoerythroblastic 
reaction or the presence of abnormal cells. Bone 
marrow examination showed hypercellular marrow 
and massive infestation with the amastigote form of 
Leishmania donovani in the bone marrow macro-
phages and in some granulocytes. Written informed 
consent was obtained from the patient.
The visceral form of Leishmaniasis can be fatal if 
not treated in a timely fashion and stibogluconate 
(sodium antimony gluconate) is the drug of choice. 
Recently, other agents have become available for 
the treatment of new and resistant cases of visceral 
Leishmaniasis, including pentamidine isethionate, 
amphotericin B, miltefosine, and paramomycin [1]. 
The  presented  patient  received  anti-leishmanial 
treatment with sodium antimony gluconate 20 mg/
kg/d for 14 d. She began to exhibit improvement 
within  3  d  and  was  clinically  cured  after  the  full 
course of therapy. She was last followed-up 1 month 
after completion of the treatment and was asymp-
tomatic and healthy.
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